Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
8.77
-0.45 (-4.88%)
At close: Sep 25, 2026, 4:00 PM EDT
8.99
+0.22 (2.51%)
Pre-market: Sep 28, 2026, 4:00 AM EDT
Q32 Bio Employees
Q32 Bio had 22 employees as of June 30, 2026. The number of employees decreased by 6 or -21.43% compared to the same quarter last year.
Employees
22
Change
-6
Growth
-21.43%
Revenue / Employee
$2,442,591
Profits / Employee
$1,535,727
Market Cap
261.08M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 22 | -6 | -21.43% | 22 | 0 |
| Mar 31, 2026 | 22 | -7 | -24.14% | 22 | 0 |
| Dec 31, 2025 | 24 | -19 | -44.19% | 24 | 0 |
| Sep 30, 2025 | 26 | -17 | -39.53% | 26 | 0 |
| Jun 30, 2025 | 28 | -15 | -34.88% | 27 | 1 |
| Mar 31, 2025 | 29 | -10 | -25.64% | 28 | 1 |
| Dec 31, 2024 | 43 | 6 | 16.22% | 42 | 1 |
| Sep 30, 2024 | 43 | 8 | 22.86% | 42 | 1 |
| Jun 30, 2024 | 43 | 8 | 22.86% | 41 | 2 |
| Mar 31, 2024 | 39 | - | - | 39 | 0 |
| Dec 31, 2023 | 37 | - | - | 37 | 0 |
| Sep 30, 2023 | 35 | - | - | 35 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Sutro Biopharma | 128 |
| AC Immune | 122 |
| Invivyd | 122 |
| Zentalis Pharmaceuticals | 106 |
| Lineage Cell Therapeutics | 77 |
| Lexeo Therapeutics | 63 |
| Immuneering | 57 |
QTTB News
- 6 days ago - Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Congress 2026 - PRNewsWire
- 12 days ago - Q32 Bio Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 13 days ago - Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D. - PRNewsWire
- 18 days ago - Q32 Bio Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 19 days ago - Q32 Bio Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 26 days ago - Q32 Bio to Participate in Upcoming September Investor Conferences - PRNewsWire
- 4 weeks ago - Q32 Bio initiated with an Overweight at Morgan Stanley - TheFly
- 7 weeks ago - Q32 Bio Quarterly report: Q2 2026 - Filings